Ligand Pharmaceuticals LGND Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's operating margin?
- Ligand Pharmaceuticals (LGND) reported operating margin of 34.5% in Q1 2026.
- How has Ligand Pharmaceuticals's operating margin changed year-over-year?
- Ligand Pharmaceuticals's operating margin increased by 201.2% year-over-year, from -34.1% to 34.5%.
- What is the long-term trend for Ligand Pharmaceuticals's operating margin?
- Over 3 years (2020 to 2025), Ligand Pharmaceuticals's operating margin has grown at a -8.7% compound annual growth rate (CAGR), from 20.1% to 15.3%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.